Opendata, web and dolomites

SAL ETHVI

Innovative, easily applicable vaccine for poultry industry against five Salmonella serovars: Enteritidis, Typhimurium, Hadar, Virchow and Infantis – SAL ETHVI

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SAL ETHVI project word cloud

Explore the words cloud of the SAL ETHVI project. It provides you a very rough idea of what is the project "SAL ETHVI" about.

hadar    innovative    market    meat    price    worldwide    risks    intervention    serovars    despite    configuration    places    2003    hatching    hens    complete    infections    poisoning    sizing    serotypes    commercialize    immunolab    human    contaminated    industry    biggest    frequently    chickens    pathogens    levels    virchow    vaccination    strategy    humans    performed    zoonotic    invented    critical    sme    breeders    sources    france    poland    78    species    owners    producers    farms    poultry    plan    feasibility    ethvi    infantis    gastrointestinal    spreading    bacteria    patent    filled    activation    vaccine    flocks    markets    netherlands    enteritidis    ultimately    chicken    typhimurium    reduce    sal    serovar    kingdom    mapping    breakthrough    salmonella    vaccines    animals    chain    certification    disease    instrument    constituting    adventage    business    competitive    safer    germany    food    risk    registration    listed    united    rates    russia    broilers    biosecurity    comprise    lower   

Project "SAL ETHVI" data sheet

The following table provides information about the project.

Coordinator
ZAKLAD BADAWCZO-WDROZENIOWY OSRODKASALMONELLA IMMUNOLAB SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA 

Organization address
address: UL. AL. ZWYCIESTWA 96/98
city: GDYNIA
postcode: 81 451
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Project website http://immunolab.com.pl/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.3.2. (SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2016-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ZAKLAD BADAWCZO-WDROZENIOWY OSRODKASALMONELLA IMMUNOLAB SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA PL (GDYNIA) coordinator 50˙000.00
2    NatVet sp. z o. o. PL (Gdansk) participant 0.00

Map

 Project objective

Salmonella species (also called serovars) are important zoonotic pathogens that cause gastrointestinal disease in humans and animals. Poultry products contaminated with these pathogens are one of the major sources of human Salmonella infections worldwide. Salmonella Enteritidis and Typhimurium are the serovars most frequently associated with human food poisoning (78.3 % of all cases in 2003). The serovars of Salmonella having places three to five are Virchow, Infantis and Hadar. Vaccination of chickens, along with other intervention measures in the overall biosecurity system of chicken farms, is an important strategy that is currently being used to reduce the levels of Salmonella in poultry flocks, which will ultimately lead to lower rates of human infections. However, despite numerous studies that have been performed, there is still a need for safer, well-defined Salmonella vaccines. At Immunolab we invented SAL ETHVI – innovative vaccine against above listed 5 serovars of Salmonella. We also breakthrough the technology for the vaccine production in a way that allows any configuration of serotypes, therefore if there is a need for a vaccine against another serovar, its production will be very easy. The end users of the vaccine will be poultry breeders, namely hens and broilers flocks owners. The unique features of our vaccine constituting our competitive adventage comprise : (1) easy application ; (2) low price ; (3) immediate vaccination upon hatching; (4) no risk of bacteria activation and spreading. We have filled a patent application for the technology and upon the vaccine registration and certification, we aim to commercialize it at the broilers markets of the biggest European poultry meat producers: Poland, Germany, France, the Netherlands, United Kingdom and Russia. We are applying for the SME Instrument Phase 1, aiming to complete the feasibility study and a business plan including industry value-chain mapping, market sizing and critical risks assessment.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAL ETHVI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SAL ETHVI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.3.2.)

CHAMPIPACK (2016)

Active packaging for extending lifespan of champignon

Read More  

PlotLab (2015)

PlotLab - Plot combines with integrated lab equipment for lean breading

Read More  

SCHOCKO3 (2015)

Novel Ozone and Thermal Shock Conservation Process for Vegetables

Read More